It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Learn how wash sale rules affect crypto capital gains in 2026, including proposed limits, reporting requirements, and strategies to optimize taxes.
26,282 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Investors confront a Musk-power dilemma: bet on SpaceX's growth trajectory or Tesla's robotics push. This analysis br...
The first watch restaurant stock has cooled off after a strong earnings showing, but the story isn’t just about numbe...
NVIDIA is expanding beyond chips into cloud AI infrastructure. This move signals a broader AI ecosystem pivot that co...
A new market model signals Netflix crossing the $100 threshold on September 18, 2026, backed by ad-supported growth, ...
An ESG equity fund has posted a double-digit gain while steering clear of Meta. Its AI-forward lineup centers on Alph...
New data released this week shows Americans facing persistent affordability pressures. Three charts highlight afforda...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
When Apple moves more of its production to the U.S., investors often respond quickly. This article explains why apple...
Teva has climbed more than 100% in the last year, and analysts remain cautiously optimistic. Here’s why wall street t...
SpaceX stock just surged after its IPO, triggering questions about valuation, risk, and whether now is the time to in...
Europe is poised to become a leader in trusted, industrialized AI as regulators push for guardrails and firms invest ...